|
GPD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.823000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.536000E-02 |
| Normal-vs-Stage2 |
7.597400E-01 |
| Normal-vs-Stage3 |
4.848200E-01 |
| Normal-vs-Stage4 |
6.355200E-01 |
| Stage1-vs-Stage2 |
1.302180E-01 |
| Stage1-vs-Stage3 |
8.463800E-02 |
| Stage1-vs-Stage4 |
6.257000E-01 |
| Stage2-vs-Stage3 |
7.570800E-01 |
| Stage2-vs-Stage4 |
6.010000E-01 |
| Stage3-vs-Stage4 |
4.753000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.347400E-01 |
| Normal-vs-AfricanAmerican |
2.791600E-01 |
| Normal-vs-Asian |
8.891000E-01 |
| Caucasian-vs-AfricanAmerican |
5.406800E-01 |
| Caucasian-vs-Asian |
7.524400E-01 |
| AfricanAmerican-vs-Asian |
5.289200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.827900E-02 |
| Normal-vs-Female |
5.394200E-02 |
| Male-vs-Female |
3.358600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.825500E-02 |
| Normal-vs-Extreme_Weight |
1.929620E-02 |
| Normal-vs-Obese |
6.401800E-01 |
| Normal-vs-Extreme_Obese |
8.991900E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.116000E-01 |
| Normal_Weight-vs-Obese |
4.955700E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.196800E-01 |
| Extreme_Weight-vs-Obese |
1.388500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.900400E-01 |
| Obese-vs-Extreme_Obese |
1.989990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.510770E-01 |
| Normal-vs-Age(41-60Yrs) |
6.426600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.063970E-01 |
| Normal-vs-Age(81-100Yrs) |
1.874820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.127610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.552100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.994100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.789180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.515800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.603600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.226000E-01 |
| Normal-VS-Type2 PRCC |
1.454140E-02 |
| Normal-VS-KIRP CIMP |
1.599630E-02 |
| Normal-VS-Unclassified PRCC |
4.906400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.661900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.384100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.084790E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.857500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.751610E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.018400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.966000E-02 |
| Normal-vs-N1 |
1.987650E-01 |
| Normal-vs-N2 |
9.909400E-01 |
| N0-vs-N1 |
2.429700E-02 |
| N0-vs-N2 |
4.067800E-01 |
| N1-vs-N2 |
2.238800E-01 |
|
|
